Project Summary Alternative strategies to conventional antibiotics are needed to combat rising antibiotic resistance in bacteria. Therapeutics that target virulence factors would instead disarm bacteria and mitigate the risk of developing antibiotic resistance. In this proposal, we investigate the disruption of bacterial surface layer proteins (SLPs), which self-assemble into a para-crystalline surface layer (S-layer), a virulence factor that mediates bacterial aggregation, adhesion, and protection. Nanobodies, which exhibit low immunogenicity in humans, and are easier to purify and deliver compared to monoclonal antibodies, were recently demonstrated to depolymerize S- layers in the case of Bacillus anthracis, which led to complete survival in mice models under sustained treatment. Our scientific premise is that nanobody-based inhibition of S-layers is a viable antivirulence strategy once tuned for each bacterial pathogen. We propose to leverage our multiscale computer simulation expertise to identify the as-yet unknown mechanism of action and to determine sequence motifs that enhance nanobody-induced S-layer depolymerization in Bacillus anthracis. Our aims include (1) verification that depolymerization is induced by S-layer rigidification through the use of coarse-grained modeling and simulation and (2) determination of nanobodies with improved antivirulence by computationally tailoring existing nanobodies. The computational protocols developed herein are systematic and generalizable beyond Bacillus anthracis. We expect our findings and computational tools to extend to other SLP-expressing bacteria, including urgent antibiotic-resistant threats such as Clostridioides difficile, and aid the global fight against antibiotic-resistant bacteria.